gabapentin has been researched along with Movement Disorders in 8 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to report our institution's experience with gabapentin therapy to manage agitation and pain in the neonatal intensive care unit (NICU) setting." | 7.96 | Gabapentin for pain, movement disorders, and irritability in neonates and infants. ( Burnsed, JC; Heinan, K; Letzkus, L; Zanelli, S, 2020) |
| "We aimed to report our institution's experience with gabapentin therapy to manage agitation and pain in the neonatal intensive care unit (NICU) setting." | 3.96 | Gabapentin for pain, movement disorders, and irritability in neonates and infants. ( Burnsed, JC; Heinan, K; Letzkus, L; Zanelli, S, 2020) |
| "In childhood, movement disorders are generated by a very large number of disorders of the nervous system, and the very different developmental ages at which these occur make studies of pharmacotherapy efficacy extremely difficult." | 2.55 | Advances in pharmacotherapies for movement disorders in children: current limitations and future progress. ( Lin, JP, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vollmer, B | 1 |
| Lin, JP | 1 |
| Alvarado-Franco, NL | 1 |
| Gonzalez-Marques, C | 1 |
| Olguín-Ramírez, LA | 1 |
| Garza-Alpirez, A | 1 |
| Femat-Roldan, G | 1 |
| Martinez-Ramirez, D | 1 |
| Burnsed, JC | 1 |
| Heinan, K | 1 |
| Letzkus, L | 1 |
| Zanelli, S | 1 |
| Fourcade, G | 1 |
| Roubertie, A | 1 |
| Doummar, D | 1 |
| Vidailhet, M | 1 |
| Labauge, P | 1 |
| Villarejo, A | 1 |
| Porta-Etessam, J | 1 |
| Camacho, A | 1 |
| González De La Aleja, J | 1 |
| Martínez-Salio, A | 1 |
| Penas, M | 1 |
| Chaná, P | 1 |
| de Marinis, A | 1 |
| Barrientos, N | 1 |
| Magnus, L | 1 |
2 reviews available for gabapentin and Movement Disorders
| Article | Year |
|---|---|
Advances in pharmacotherapies for movement disorders in children: current limitations and future progress.
Topics: Amines; Anti-Dyskinesia Agents; Child; Clonidine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Ami | 2017 |
Nonepileptic uses of gabapentin.
Topics: Acetates; Amines; Analgesics; Antimanic Agents; Antiparkinson Agents; Bipolar Disorder; Clinical Tri | 1999 |
2 trials available for gabapentin and Movement Disorders
| Article | Year |
|---|---|
Gabapentin for painful legs and moving toes syndrome.
Topics: Acetates; Aged; Amines; Cyclohexanecarboxylic Acids; Electromyography; Excitatory Amino Acid Antagon | 2004 |
Gabapentin and motor fluctuations in Parkinson's disease.
Topics: Acetates; Aged; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Drug Therapy, Combination | 1997 |
4 other studies available for gabapentin and Movement Disorders
| Article | Year |
|---|---|
Management of chronic pain in newborn infants.
Topics: Chronic Pain; Gabapentin; Humans; Infant; Infant, Newborn; Movement Disorders; Pain Management | 2020 |
Athetoid Movements as Initial Manifestation of Primary Sjögren Syndrome.
Topics: Aged; Amines; Anticonvulsants; Athetosis; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Ami | 2018 |
Gabapentin for pain, movement disorders, and irritability in neonates and infants.
Topics: Analgesics; Female; Gabapentin; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Mal | 2020 |
[Paroxysmal kinesigenic dyskinesia: a channelopathy? Study of 19 cases].
Topics: Adolescent; Adult; Age of Onset; Amines; Anticonvulsants; Channelopathies; Child; Child, Preschool; | 2009 |